HomeInsightsResults

Procter & Gamble Health Ltd Quarterly Result

Procter & Gamble Health Ltd Quarterly Result

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

0.2 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Procter & Gamble Health Ltd

NSE: PGHL

Net Profit

₹ 82.33

Last updated on: Nov 23, 2024

Key Highlights

  • The revenue of Procter & Gamble Health Ltd for the Jun '24 is ₹ 316.69 crore as compare to the Mar '24 revenue of ₹ 286.01 crore. This represent the growth of 10.726894%.
  • The ebitda of Procter & Gamble Health Ltd for the Jun '24 is ₹ 117.32 crore as compare to the Mar '24 ebitda of ₹ 30.19 crore. This represent the growth of 288.6055%.
  • The net profit of Procter & Gamble Health Ltd for the Jun '24 is ₹ 82.33 crore as compare to the Mar '24 net profit of ₹ 16.78 crore. This represent the growth of 390.64365%.

Results Analysis

Market Price of Procter & Gamble Health Ltd

1M

1Y

3Y

5Y

Monitoring Procter & Gamble Health Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20245092.55
21 Nov 20245124.1
19 Nov 20245134.95
18 Nov 20245117.4
14 Nov 20245143.95
13 Nov 20245217.4
12 Nov 20245404.55
11 Nov 20245463.35
08 Nov 20245567.55
07 Nov 20245683.85

Historical Revenue of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical EBITDA of Procter & Gamble Health Ltd

No data available

* All values are in crore

Historical Net Profit of Procter & Gamble Health Ltd

No data available

* All values are in crore

Procter & Gamble Health Ltd News Hub

News

P&G Health hits 52 week high as Q2 PAT jumps 26% YoY to Rs 82 cr

Profit before tax in Q2 FY25 stood at Rs 111.4 crore, up 26.51% as against Rs 88.05 crore ...

Read more

05 Nov 202409:59

News

Procter & Gamble Health to hold board meeting

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 4 ...

Read more

28 Sep 202410:06

News

Procter & Gamble Health schedules AGM

Procter & Gamble Health announced that the 57th Annual General Meeting (AGM) of the compan...

Read more

23 Aug 202411:48

News

P&G Health slides as Q4 PAT drops 44% YoY to Rs 17 cr

Revenue from operations slipped 5.74% year on year to Rs 283.88 crore during the quarter, ...

Read more

22 Aug 202410:02

News

Board of Procter & Gamble Health recommends final dividend

Procter & Gamble Health announced that the Board of Directors of the Company at its meetin...

Read more

21 Aug 202417:54

News

Procter & Gamble Health announces board meeting date

Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 21...

Read more

28 Jun 202411:17

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Procter Gamble Health Ltd Quarterly Result

What is the EPS of Procter & Gamble Health Ltd stock?

The Earnings Per Share (EPS) of Procter & Gamble Health Ltd is 136.52. An EPS is the amount of net income attributed to each share of a common stock.

How is Procter & Gamble Health Ltd EPS calculated?

The EPS of Procter & Gamble Health Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Procter & Gamble Health Ltd report its EPS?

Procter & Gamble Health Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Procter & Gamble Health Ltd EPS?

Factors that influence the EPS of Procter & Gamble Health Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Procter & Gamble Health Ltd EPS growth indicate future performance?

Yes, consistent growth in Procter & Gamble Health Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*